You are here: Industry Insights > COVID-19

News List

CARE Receives May Proceed Letter from FDA for COVID-19 Trial americanpharmaceuticalreview
November 17, 2020
Senhwa Biosciences announced its clinical partner, Center for Advanced Research and Education (CARE) in Gainesville, Georgia, has received a Study May Proceed letter from the US Food and Drug Administration (FDA) to begin a phase II ...
Canakinumab Study Fails to Meet Primary Endpoint americanpharmaceuticalreview
November 17, 2020
Novartis announced new data from an interim analysis for the randomized, double-blind, placebo-controlled CAN-COVID trial evaluating the efficacy and safety of canakinumab in hospitalized patients with COVID-19 pneumonia and cytokine release syndrome.
UK study shows SNG001 aids in faster Covid-19 recovery pharmaceutical-technology
November 17, 2020
The University of Southampton in the UK has published the results from a clinical trial of an inhaled form of interferon beta-1a, SNG001, which reduced chances of hospitalised Covid-19 patients developing severe disease or death due to infection.
Indian firm Biological E initiates clinical trial of Covid-19 vaccine candidate pharmaceutical-technology
November 17, 2020
Indian pharma firm Biological E (BE) has initiated a Phase I/II clinical trial to evaluate the safety and immunogenicity of its Covid-19 subunit vaccine candidate.
Vaccine is 94.5 per cent effective in preventing COVID-19: Moderna expresspharma
November 17, 2020
Moderna said its experimental vaccine was 94.5 per cent effective in preventing COVID-19 based on interim data from a late-stage clinical trial, becoming the second US company to report results that far exceed expectations.
PTC Therapeutics Announces Initiation of Phase 2/3 Clinical Trial in Australia to Evaluate PTC299 for the Treatment of COVID-19 prnasia
November 16, 2020
PTC Therapeutics, Inc., today announced the initiation of a Phase 2/3 trial called FITE19 to investigate PTC299, a dihydroorotate dehydrogenase (DHODH) inhibitor, as a potential treatment for COVID-19.
Cytiva supports Clover Biopharmaceuticals to scale up the output of its vaccine candidate prnasia
November 16, 2020
Cytiva, a global life sciences leader, is supporting Clover Biopharmaceuticals, a global clinical-stage biotechnology company, to help accelerate the development and manufacturing of a protein-based S-Trimer subunit vaccine candidate.
NeuroRx and Relief Therapeutics announce enrollment of 150 patients in phase 2b/3 trial of RLF-100? for Critical COVID-19 with Respiratory Failure prnewswire
November 16, 2020
NeuroRx, Inc. and Relief Therapeutics Holdings AG announced that as of today, 150 patients (out of a targeted enrollment of 165) have been enrolled in the ongoing phase 2b/3 trial of RLF-100? (aviptadil) for treating respiratory failure in patients with..
Fluvoxamine may prevent serious illness in COVID-19 patients worldpharmanews
November 16, 2020
In a preliminary study of COVID-19 patients with mild-to-moderate disease who were attempting to recover in their homes, researchers at Washington University School of Medicine in St. Louis have found that the drug fluvoxamine seems to prevent some of ...
Packaging initiative to protect COVID-19 medicines against counterfeiting launched europeanpharmaceuticalreview
November 16, 2020
The AlpVision COVID-19 Initiative will provide pharma companies with access to use a crytoglyph on their medicine packaging for free.